click below
click below
Normal Size Small Size show me how
platelets&hemostasis
MTSU Stegall-Faulk Anatomy 2
| Term | Definition |
|---|---|
| platelets | cell fragments of megakarycytes. |
| platelets | large amounts in the spleen. initiate and control clotting process form a patch with myosin and actin fibers. |
| glycoproteins | stick on the surface |
| thrombopoietin | hormone stimulates formation of platelets |
| hemostasis | cessation of bleeding |
| 3 mechanisms that prevent blood loss from damaged vessels | vascular spasm, platelet plug formation, and coagulation |
| vascular spasms | wall of blood vessel, smooth muscle within the wall contracts, reducing the diameter of the vessel and reducing the blood flow. |
| platelet adhesion | stick to the exposed collagen and other endothelial cells. |
| platelet activation | activated and release several substances by exocytosis |
| ADP | attract more platelets, cause platelets to swell |
| thromboxanes | stimulate more vascular spasm and sttract more platelets |
| platelet activation | ADP, thromboxanes, serotonin, clotting factors, calcium ions, and control of platelet activation and aggregation. |
| clotting phase | the ultimate goal is the conversation of circulating soluble fibrinogen into insoluble fibrin. |
| extrinsic pathway | initiated by tissue and or vessel injury. release from vessel walls>tissue factor CF3> activate CF10> common pathway |
| intrinsic pathway | initiated by substances within the blood. released from platlets> inactive CF7 exposed collegen and activates CF7> activate CF10> common pathway |
| common pathway | activates CF10 |
| Prothrombinase | catalyzes the conversion of prothrombin into thrombin |
| thrombin and calcium | catalyze the conversion of fibrinogen into fibrin(insoluble) |
| clot retraction | 30-60 minutes. actin and myosin contract |
| fibrinolysis | scab reducing in size by breaking down insoluble fiber |
| plasminogen | proenzyme for breaking down activation by thrombin |
| IV streptokinase | breakdown clot |
| t-PA | issue plasminagen activator to break down |
| thrombocytopenia | platelet count below 100,000 |
| thrombosis | abnormal clotting in a closed blood vessel |